Comparison between single-agent and combination chemiotherapy against uterine mesenchymal tumors. Doxorubicine for LMS and ifosfamide and cisplatin for MMT are the most effective antineoplastic drugs in single-agent chemiotherapy. Combination chemiotherapy increases response rate as well as toxicity, but the impact on survival is unclear.

Chemotherapy in Uterine Mesenchymal Tumors

BERGAMINI, VALENTINO;FRANCHI, Massimo Piergiuseppe
2004

Abstract

Comparison between single-agent and combination chemiotherapy against uterine mesenchymal tumors. Doxorubicine for LMS and ifosfamide and cisplatin for MMT are the most effective antineoplastic drugs in single-agent chemiotherapy. Combination chemiotherapy increases response rate as well as toxicity, but the impact on survival is unclear.
single- agent; combination chemiotherapy; mesenchimal tumors
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/428838
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact